CASTLE BIOSCIENCES INC
CSTL · XNASCIK 1447362fmd_15EJ3ZDV6F6BY1TZ25GXW14SG7Services · Services-Medical LaboratoriesTemplate: Standard
Coverage: Jan 01, 2018 to Sep 30, 2026, 35 periods
| Line item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Total revenues | 23 | 52 | 63 | 94 | 137 | 220 | 332 | 344 |
| Cost of revenue | 5 | 7 | 10 | 16 | 32 | 45 | 60 | 71 |
| Gross profit | 17 | 45 | 53 | 78 | 105 | 175 | 272 | 273 |
| Research and development | 5 | 7 | 13 | 30 | 45 | 54 | 52 | 52 |
| Selling, general and administrative | 16 | 30 | 48 | 87 | 143 | 180 | 200 | 229 |
| Total operating expenses | 21 | 37 | – | – | – | – | – | – |
| Operating income | (4) | 7 | (7) | (40) | (73) | (68) | 9 | (43) |
| Interest expense | 2 | 5 | 3 | 0 | 0 | 0 | 1 | 0 |
| Interest and investment income | 0 | 0 | 0 | 0 | 4 | 11 | 13 | 12 |
| Other non-operating income (expense) | (0) | (3) | 0 | – | – | 0 | 0 | 0 |
| Income tax expense | 0 | 0 | 0 | (9) | (2) | 0 | 3 | (5) |
| Net income | (6) | 5 | (10) | (31) | (67) | (57) | 18 | (24) |
| Net income to common shareholders | (10) | 3 | (10) | – | – | – | – | – |